Abstract
Abstract Chronic pain patients are often challenged with depression stemming from the long-term physiopsychological effects of their condition. Consequently, chronic pain patients are often treated with morphine, which can induce immunosuppression, along with an antidepressant. The antidepressant, Citalopram, is a serotonin reuptake inhibitor that may have immunomodulatory effects. We investigated whether Citalopram has immunoenhancing effects on morphine-induced immune suppression. Adult mice were pretreated for 7 days with either saline or Citalopram (10 or 30 mg/kg, twice daily intraperitoneal injections), followed by immunosuppression by subcutaneous implantation of a 25 mg morphine pellet for 48 h. Spleen, thymus, and lymph nodes were harvested to analyze total cell numbers. Total splenocyte numbers in all Citalopram-treated animals were significantly higher than saline-treated animals, while no differences were found in the thymus or lymph nodes. More specifically, a high dose of Citalopram (30 mg/kg) resulted in significantly higher B cell numbers in the lymph nodes, where T cell and NK cell numbers were not different. Interestingly, splenic lymphocyte populations did not differ between treatments. In summary, Citalopram may have a specific potential in the attenuation of morphine’s immunosuppressive effect by enhancing splenocyte numbers and lymph node B cell populations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.